MedPath

Effect of Baladi Ghrita along with Ferrous Ascorbate in the Treatment of Pica associated Anemia

Phase 2
Conditions
Health Condition 1: R688- Other general symptoms and signs
Registration Number
CTRI/2023/10/058275
Lead Sponsor
DrKiran Laxmanrao Kudmate
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient will be selected irrespective of their gender, caste and socioeconomic status.

2. Patient’s age group between 2-6 years.

3. Hb% >8 gm/dl and <11gm/dl

Exclusion Criteria

1) Patient having any major systemic illness.

2) Patients below 2 year and above 6 years.

3) Patients with defective iron absorption in condition like gastrostomy, gastro-jejunostomy.

4) Anemia due to chronic illness like malaria, T.B, Leukemia, etc .

5) K/C/O Congenital anomalies, ADHD, Mentally retarded.

6) Hb% <8 gm/dl and >11 gm/dl

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Study of add on effect of Baladi Ghrita in the management of Mridbhakshanjanya Pandu <br/ ><br>when given orally along with ferrous ascorbate on Pallor, Hb% , MCV, RDW-CVTimepoint: 4 Weeks
Secondary Outcome Measures
NameTimeMethod
To study the clinical appearance of Mridbhakshanjany Pandu occurring in <br/ ><br> Children according to both Ayurvedic & modern point of view.Timepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath